Sterling Bancorp (STL) 16.71 $STL Sterling Bancorp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sterling Bancorp (STL) 16.71 $STL

Sterling Bancorp Announces Record Results for the Three and Six Months Ended June 30, 2016. Strong Operating Momentum in the Second Quarter Continues, Highlighted by GAAP Diluted Earnings per Share of $0.29, Adjusted Diluted Earnings per Share(1) of $0.27
Marketwire Canada - Tue Jul 26, 3:10PM CDT
MONTEBELLO, NY--(Marketwired - July 26, 2016) -
STL: 16.71 (-0.14)

Sterling Enters Agreement to Sell Residential Mortgage Origination Operations
Marketwired - Tue Jul 26, 3:09PM CDT
MONTEBELLO, NY--(Marketwired - July 26, 2016) - Sterling Bancorp (NYSE: STL), through its principal subsidiary Sterling National Bank ("Sterling", announced today that it has entered into an agreement to sell its residential mortgage origination operations. The transaction is subject to certain licensing and regulatory approval and other customary closing conditions.
STL: 16.71 (-0.14)

Sterling Bancorp Declares Quarterly Dividend of $0.07 per Share
Marketwire Canada - Tue Jul 26, 3:05PM CDT
MONTEBELLO, NY--(Marketwired - July 26, 2016) - Sterling Bancorp (NYSE: STL), the parent company of Sterling National Bank, today announced that the Board of Directors has declared a quarterly cash dividend of $0.07 per share. The dividend is payable August 23, 2016 to holders of record as of August 8, 2016.
STL: 16.71 (-0.14)

Ameri100 Secures $10 Million Financing with Sterling National Bank
PR Newswire - Wed Jul 06, 7:30AM CDT
AMERI Holdings, Inc. ("Ameri100" or the "Company" (OTCQB: AMRH), a SAP-based strategy consulting firm that brings synergies of classic technology consulting and product-based technology consulting services to its customer base, today announced that on July 1, 2016 it closed a $10 million credit facility with Sterling National Bank, principal subsidiary of Sterling Bancorp (NYSE: STL). The Company plans to use this line of credit to further its expansion strategy of acquiring SAP-based IT services and consulting companies.
STL: 16.71 (-0.14)

What These Banking Stocks Have in Their Performance Vaults? - Mitsubishi UFJ Financial, FirstMerit, Sterling Bancorp., and Great Western Bancorp
PR Newswire - Tue May 31, 7:15AM CDT
The Financial sector has seen some significant improvement since the beginning of this year, thus presenting many investors with growth opportunities. Ahead of today's trading session, ActiveWallSt.com has released trade alerts on the following Money Center Banks equities: Mitsubishi UFJ Financial Group Inc. (NYSE: MTU), FirstMerit Corp. (NASDAQ: FMER), Sterling Bancorp. (NYSE: STL), and Great Western Bancorp. Inc. (NYSE: GWB). Sign up for these stocks' alerts by clicking on the following link:
FMER: 20.82 (-0.23), MTU: 4.91 (-0.26), STL: 16.71 (-0.14), GWB: 31.88 (-0.86)

Sterling Bancorp posts 1Q profit
Automated Insights - Tue Apr 26, 4:27PM CDT
MONTEBELLO, N.Y. (AP) _ Sterling Bancorp (STL) on Tuesday reported first-quarter net income of $23.8 million.
STL: 16.71 (-0.14)

Sterling Bancorp Announces Results for the Three Months Ended March 31, 2016
Marketwired - Tue Apr 26, 3:18PM CDT
Sterling Bancorp (NYSE: STL) , the parent company of Sterling National Bank (the "Company", today announced results for the three months ended March 31, 2016. Net income for the quarter was $23.8 million, or $0.18 per diluted share, compared to net income of $32.8 million, or $0.25 per diluted share, for the linked quarter ended December 31, 2015 and net income of $16.8 million, or $0.19 per diluted share, for the first quarter of 2015.
STL: 16.71 (-0.14)

Sterling Bancorp to Announce First Quarter 2016 Results
Marketwired - Mon Apr 11, 3:10PM CDT
Sterling Bancorp (NYSE: STL), the parent company of Sterling National Bank, today announced that it plans to release results for the first quarter ended March 31, 2016 after the market close on Tuesday, April 26, 2016.
STL: 16.71 (-0.14)

Sterling Bancorp Acquires NewStar Business Credit, LLC
Marketwired - Thu Mar 31, 3:38PM CDT
Sterling Bancorp (NYSE: STL), through its principal subsidiary, Sterling National Bank, announced today that it has completed the acquisition of NewStar Business Credit, LLC ("NSBC". NSBC is a wholly owned subsidiary of NewStar Financial Inc. (NASDAQ: NEWS), a provider of specialized direct lending and credit management capabilities for middle market companies and investors in the credit markets. Sterling will acquire client relationships with over $330 million in loan outstandings as of March 31, 2016, doubling its existing asset-based lending loan portfolio. Sterling is a leading secured lender with an established national asset-based lending platform and has been a trusted financial services provider for over 125 years.
NEWS: 10.18 (+0.05), STL: 16.71 (-0.14)

NewStar Sells Asset-based Lending Business To Sterling National Bank
GlobeNewswire - Thu Mar 31, 3:01PM CDT
NewStar Financial Inc. (Nasdaq:NEWS) ("NewStar" or the "Company" announced today the sale of its asset-based lending subsidiary, NewStar Business Credit LLC ("NSBC", to Sterling National Bank ("Sterling", a wholly owned subsidiary of Sterling Bancorp (NYSE:STL) for approximately $112 million in cash, net of debt repayment, fees and transaction expenses.
NEWS: 10.18 (+0.05), STL: 16.71 (-0.14)

Sterling National Bank Announces Pricing of Subordinated Notes Offering
Marketwired - Wed Mar 23, 5:21PM CDT
Sterling National Bank (the "Bank", a wholly owned subsidiary of Sterling Bancorp (NYSE: STL), today announced that it has priced an offering of $105 million aggregate principal amount of its 5.25% fixed-to-floating rate subordinated notes due 2026 (the "Notes". The offering is expected to close on or about March 29, 2016, subject to customary closing conditions.
STL: 16.71 (-0.14)

Oversold Conditions For Sterling Bancorp (STL)
MarketNewsVideo.com - Mon Feb 08, 11:15AM CST
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
STL: 16.71 (-0.14)

Sterling Bancorp Announces Results for the Three Months and Full Year Ended December 31, 2015
Marketwired - Wed Jan 27, 3:10PM CST
Key Highlights for the Full Year ended December 31, 2015
STL: 16.71 (-0.14)

Metropolitan Commercial Bank names new board member
M2 - Thu Jan 21, 6:06AM CST
Metropolitan Commercial Bank has appointed 25-year banking executive Dale C. Fredston to its board of directors. Fredson's experience as a senior banking executive and attorney is expected to enhance the bank's risk management and its positioning for continued growth with exceptional customer and community service. Prior to joining the Metropolitan Commercial Bank Board, she was executive vice president and general counsel of Sterling Bancorp (NYSE: STL) and its principal subsidiary, Sterling National Bank. Metropolitan Commercial Bank, founded in 1999 and headquartered in New York City, is a full-service commercial bank with banking centers in Manhattan; Borough Park, Brooklyn; and Great Neck, Long Island.
STL: 16.71 (-0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading